APA (7th ed.) Citation

GM, B., CL, C., JR, R., & DF, B. (2013). Recombinant activated factor VII use in critically ill patients: Clinical outcomes and thromboembolic events. The Annals of pharmacotherapy, 47(4), 447. https://doi.org/10.1345/aph.1R729

Chicago Style (17th ed.) Citation

GM, Brophy, Candeloro CL, Robles JR, and Brophy DF. "Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events." The Annals of Pharmacotherapy 47, no. 4 (2013): 447. https://doi.org/10.1345/aph.1R729.

MLA (9th ed.) Citation

GM, Brophy, et al. "Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events." The Annals of Pharmacotherapy, vol. 47, no. 4, 2013, p. 447, https://doi.org/10.1345/aph.1R729.